Promising Trials on Covid 19
Some New York hospitals are reporting success using the plasma of infected and recovered patients, and the FDA has issued guidance for its investigational use. https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma
Some researchers are reporting that a drug called EIDD 2801 holds promise to derail Covid 19 infections. https://www.npr.org/sections/coronavirus-live-updates/2020/04/06/828322576/promising-drug-on-the-horizon-for-covid-19
There are also drugs that appear to be mostly hype, such as President Trump’s personal favorites chloroquine and hydroxychloroquine, but who knows. https://www.thelocal.it/20200406/what-are-the-most-promising-treatments-for-covid-19
A recent article in the New York Times summarizes the more promising avenues for investigation. https://www.nytimes.com/2020/04/07/opinion/coronavirus-treatment.html
The Gates Foundation is supporting a vaccine developed by Innovio that is just entering human test trials. https://techcrunch.com/2020/04/06/a-second-potential-covid-19-vaccine-backed-by-bill-and-melinda-gates-is-entering-human-testing/
The NIH and Moderna started human trials on a different tack for a vaccine in the middle of March. https://techcrunch.com/2020/03/16/first-clinical-human-trial-of-potential-coronavirus-vaccine-set-to-start-monday/
The University of Pittsburgh reports that it has has developed a promising test vaccine in mice. https://www.sciencealert.com/scientists-in-pittsburgh-say-they-ve-already-developed-a-covid-19-vaccine-candidate
Prepared by: Lucien Wulsin
Dated: 4/8/20